Consistent with the interpretation that the elevated expression of Aβ1–42 in this AD mouse model does not influence steady-state levels of other APP-expression products, peptides assigned to APP that map to regions outside of the Aβ1–42 domain were present at identical levels in homozygotes and heterozygotes. Here, APP is linked to Alzheimer disease.